Ekso Bionics Holdings, Inc..
EKSO.US | Manufacture of medical and dental instruments and supplies
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeletons. These are wearable robotic devices that enhance human strength, endurance, and mobility. The company primarily serves the medical and industrial markets. In the medical field, Ekso Bionics offers exoskeletons for rehabilitation...Show More
Better Health for All
0
The company's core products, exoskeletons, provide substantial health benefits, enabling independent walking for patients with mobility impairments, improving gait, muscle strength, bladder/bowel function, and mood.
1
For example, one patient's walking distance increased from ~10 steps to over 1,200 steps, and studies show up to 80% improvement in bowel management.
2
There is no evidence of harmful products or activities.
3
The company's Ekso Indego Personal exoskeleton has Medicare and VA coverage, but individual insurance coverage is case-by-case, and a Medicare payment rate of $91,032 was finalized for 2024, which is a high cost relative to median income.
4
The company targets individuals with spinal cord injuries (T3-L5).
5
The company trains therapists on device usage.
6
It mentions data capture and secure cloud storage for patient progress, and 74 clinical studies were completed as of July 2020 with over 1,800 participants.
7
Fair Money & Economic Opportunity
0
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeletons for medical and industrial markets.
1
The company's core business does not involve lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility for financial data, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion for banking services, and product simplicity for financial products, are not applicable to Ekso Bionics' operations. The company's products are medical devices, and while they serve populations with specific medical needs (e.g., spinal cord injuries, veterans, Medicare/Medicaid beneficiaries), this does not constitute offering financial services to underserved segments as defined by the rubric.
2
Fair Pay & Worker Respect
-40
Employee engagement scores vary across platforms, with Glassdoor reviews indicating an overall rating of 3.8 out of 5 stars from 27 reviews, and 59% of employees recommending the company.
1
However, Indeed reviews show a lower overall rating of 3.1 out of 5 stars from 7 reviews, with management rated at 1.8 out of 5 stars and culture at 2.8 out of 5 stars.
2
The CEO approval rating on Glassdoor is 46%.
3
Multiple reviews across platforms cite poor management, micromanagement, and a toxic work environment.
4
The company has experienced repeated layoffs, with five occurring in five years, suggesting a high turnover rate.
5
Fair Trade & Ethical Sourcing
0
No evidence available to assess Ekso Bionics Holdings, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Ekso Bionics Holdings, Inc. on Honest & Fair Business.
Kind to Animals
0
No evidence available to assess Ekso Bionics Holdings, Inc. on Kind to Animals.
No War, No Weapons
-50
Ekso Bionics' core exoskeleton technology is inherently dual-use, serving both medical and industrial markets while also being actively developed for military applications through contracts with DARPA and the U.S. Special Operations Command (SOCOM).
1
U.S. agencies have expressed concerns about the military applications of these exoskeletons, and the company's joint venture in China was prevented by CFIUS due to national security concerns related to its robotics.
2
The company's business operations are subject to economic and trade sanctions laws, and it reported sales to customers in Russia, a sanctioned country, representing 3% of total revenues in 2023 and 7% in 2022.
3
While the company mentions a Human Rights and Labor Standards Policy, it publicly cites UN Guiding Principles (UNGP) alignment without evidence of third-party audits or specific implementation details.
4
Planet-Friendly Business
-20
The provided articles primarily focus on the company's financial performance and general business analysis. was unprocessable.
1
explicitly states that it does not provide data on environmental, social, or governance (ESG) metrics.
2
However, it does mention that "No specific regulatory actions, violations, fines, or compliance issues are mentioned" for the full year 2024.
3
This indicates zero environmental compliance violations. No other specific, concrete data points related to environmental performance, such as greenhouse gas emissions, renewable energy usage, water consumption, waste diversion, or climate targets, were found across any of the articles.
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles regarding Ekso Bionics's formal partnerships with indigenous or local community groups, revenue reinvested in local community development, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, grievance mechanisms, community complaint resolution times, FPIC participation rates, community governance inclusion, cultural preservation investment, local procurement share, indigenous supplier engagement, cultural site protection, social license to operate, charitable giving to cultural heritage organizations, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training completion.
Safe & Smart Tech
0
No evidence available to assess Ekso Bionics Holdings, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific data on waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back program coverage, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education is provided in the articles. The 2021 Form 10-K explicitly states a lack of such sustainability metrics.
1
While one article mentions actuators are durable with over a million cycles,
2
this is for a component and lacks comparison to an industry standard for the overall product lifespan, which is required by the KPI.